Literature DB >> 24721886

Novel treatments of autosomal dominant polycystic kidney disease.

Rex L Mahnensmith1.   

Abstract

Entities:  

Keywords:  ADPKD; mTOR inhibitors; somatostatin analogs; statins; vasopressin antagonists

Mesh：

Substances：

Year:  2014        PMID： 24721886      PMCID： PMC4011435          DOI： 10.2215/CJN.02480314

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  42 in total

1.  Cyst decompression surgery for autosomal dominant polycystic kidney disease.

Authors:  L W Elzinga; J M Barry; V E Torres; H Zincke; H W Wahner; S Swan; W M Bennett
Journal:  J Am Soc Nephrol       Date:  1992-01       Impact factor: 10.121

2.  Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat.

Authors:  Xiaofang Wang; Vincent Gattone; Peter C Harris; Vicente E Torres
Journal:  J Am Soc Nephrol       Date:  2005-02-23       Impact factor: 10.121

3.  Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease.

Authors:  Piero Ruggenenti; Andrea Remuzzi; Patrizia Ondei; Giorgio Fasolini; Luca Antiga; Bogdan Ene-Iordache; Giuseppe Remuzzi; Franklin H Epstein
Journal:  Kidney Int       Date:  2005-07       Impact factor: 10.612

4.  The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.

Authors:  A B Chapman; A Johnson; P A Gabow; R W Schrier
Journal:  N Engl J Med       Date:  1990-10-18       Impact factor: 91.245

5.  Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).

Authors:  Patricia R Wahl; Andreas L Serra; Michel Le Hir; Klaus D Molle; Michael N Hall; Rudolf P Wüthrich
Journal:  Nephrol Dial Transplant       Date:  2005-10-12       Impact factor: 5.992

Review 6.  Molecular genetics of autosomal dominant polycystic kidney disease.

Authors:  York Pei
Journal:  Clin Invest Med       Date:  2003-10       Impact factor: 0.825

7.  Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.

Authors:  Arlene B Chapman; Lisa M Guay-Woodford; Jared J Grantham; Vicente E Torres; Kyongtae T Bae; Deborah A Baumgarten; Philip J Kenney; Bernard F King; James F Glockner; Louis H Wetzel; Marijn E Brummer; W Charles O'Neill; Michelle L Robbin; William M Bennett; Saulo Klahr; Gladys H Hirschman; Paul L Kimmel; Paul A Thompson; J Philip Miller
Journal:  Kidney Int       Date:  2003-09       Impact factor: 10.612

8.  Effect of somatostatin on vasopressin-induced antidiuresis and renal cyclic AMP of rats.

Authors:  S N Winkler; S Torikai; B S Levine; K Kurokawa
Journal:  Miner Electrolyte Metab       Date:  1982-01

9.  Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Xiaofang Wang; Qi Qian; Stefan Somlo; Peter C Harris; Vincent H Gattone
Journal:  Nat Med       Date:  2004-02-29       Impact factor: 53.440

10.  Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease.

Authors:  Melissa A Cadnapaphornchai; Diana M George; Kim McFann; Wei Wang; Berenice Gitomer; John D Strain; Robert W Schrier
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 8.237
View more
  3 in total

1.  Inhibition of cyst growth in PCK and Wpk rat models of polycystic kidney disease with low doses of peroxisome proliferator-activated receptor γ agonists.

Authors:  Stephanie M Flaig; Vincent H Gattone; Bonnie L Blazer-Yost
Journal:  J Transl Int Med       Date:  2016-09-23

2.  Independent Role of Underlying Kidney Disease on Renal Prognosis of Patients with Chronic Kidney Disease under Nephrology Care.

Authors:  Luca De Nicola; Michele Provenzano; Paolo Chiodini; Silvio Borrelli; Carlo Garofalo; Mario Pacilio; Maria Elena Liberti; Adelia Sagliocca; Giuseppe Conte; Roberto Minutolo
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

3.  Patient Survey of current water Intake practices in autosomal dominant Polycystic kidney disease: the SIPs survey.

Authors:  Ragada El-Damanawi; Tess Harris; Richard N Sandford; Fiona E Karet Frankl; Thomas F Hiemstra
Journal:  Clin Kidney J       Date:  2017-02-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.